These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32113664)

  • 1. Temporal changes in left ventricular ejection fraction and their prognostic impacts in patients with Stage B heart failure.
    Aoyanagi H; Nochioka K; Sakata Y; Miura M; Shiroto T; Abe R; Kasahara S; Sato M; Fujihashi T; Yamanaka S; Hayashi H; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    Int J Cardiol; 2020 May; 306():123-132. PubMed ID: 32113664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Clinical Characteristics and Short-Term Prognosis in Patients With Cardiogenic Shock and Various Left Ventricular Ejection Fractions After Acute Myocardial Infarction.
    Jiang Y; Boris AF; Zhu Y; Gan H; Hu X; Xue Y; Xiang Z; Sasmita BR; Liu G; Luo S; Huang B
    Am J Cardiol; 2022 Mar; 167():20-26. PubMed ID: 34986988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of mid-range ejection fraction following acute coronary syndrome (ANZACS-QI 23).
    Chan D; Doughty RN; Lund M; Lee M; Poppe K; Kerr AJ
    N Z Med J; 2021 Jan; 134(1528):57-78. PubMed ID: 33444307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital and long-term prognoses of patients with a mid-range ejection fraction after an ST-segment myocardial infarction.
    Karabağ Y; Çınar T; Çağdaş M; Rencüzoğulları İ; Tanık VO
    Acta Cardiol; 2019 Aug; 74(4):351-358. PubMed ID: 30136621
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic Significance of Post-Procedural Left Ventricular Ejection Fraction Following Atrial Fibrillation Ablation in Patients With Systolic Dysfunction.
    Yazaki K; Ejima K; Kataoka S; Higuchi S; Kanai M; Yagishita D; Shoda M; Hagiwara N
    Circ Rep; 2020 Nov; 2(12):707-714. PubMed ID: 33693200
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
    Tsuji K; Sakata Y; Nochioka K; Miura M; Yamauchi T; Onose T; Abe R; Oikawa T; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
    Eur J Heart Fail; 2017 Oct; 19(10):1258-1269. PubMed ID: 28370829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of acute myocardial infarction patients with mid-range ejection fraction after emergency percutaneous coronary intervention.
    Jiang Y; Hu S; Cao M; Li X; Zhou J; Ding B; Zhang F; Chen T; Zhou Y
    Postgrad Med J; 2019 Jul; 95(1125):355-360. PubMed ID: 31129629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile and causes of death according to ejection fraction in patients with heart failure cared for in a specialized Cardiology unit.
    Barge-Caballero E; Montero-Fole B; Barge-Caballero G; Couto-Mallón D; Paniagua-Martín MJ; Pardo-Martínez P; Sagastagoitia-Fornie M; Muñiz J; Vázquez-Rodríguez JM; Crespo-Leiro MG
    Rev Clin Esp (Barc); 2022 Mar; 222(3):152-160. PubMed ID: 35227424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impacts of dynamic cardiac structural changes in heart failure patients with preserved left ventricular ejection fraction.
    Yamanaka S; Sakata Y; Nochioka K; Miura M; Kasahara S; Sato M; Aoyanagi H; Fujihashi T; Hayashi H; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    Eur J Heart Fail; 2020 Dec; 22(12):2258-2268. PubMed ID: 32592517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History.
    Gentile P; Merlo M; Cannatà A; Gobbo M; Artico J; Stolfo D; Gigli M; Ramani F; Barbati G; Pinamonti B; Sinagra G
    J Am Heart Assoc; 2019 Sep; 8(17):e010705. PubMed ID: 31431100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.
    Jackson CE; Castagno D; Maggioni AP; Køber L; Squire IB; Swedberg K; Andersson B; Richards AM; Bayes-Genis A; Tribouilloy C; Dobson J; Ariti CA; Poppe KK; Earle N; Whalley G; Pocock SJ; Doughty RN; McMurray JJ;
    Eur Heart J; 2015 May; 36(18):1106-14. PubMed ID: 25616644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Impact of the Renal Resistive Index on Future Cardiovascular Events in Hospitalized Atherosclerotic Cardiovascular Patients According to Left Ventricular Ejection Fraction　- The Jichi Vascular Hemodynamics in Hospitalized Cardiovascular Patients (J-VAS) Study.
    Kotruchin P; Hoshide S; Ueno H; Shimizu H; Komori T; Kario K
    Circ J; 2020 Aug; 84(9):1544-1551. PubMed ID: 32741880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and echocardiographic characteristics of patients with preserved versus mid-range ejection fraction.
    Marai I; Andria N; Grosman-Rimon L; Hazanov E; Kinany W; Ghanim D; Amir O; Carasso S
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):503-508. PubMed ID: 32959095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST-Segment Elevation Myocardial Infarction.
    Margolis G; Khoury S; Ben-Shoshan J; Letourneau-Shesaf S; Flint N; Keren G; Shacham Y
    Am J Cardiol; 2017 Jul; 120(2):186-190. PubMed ID: 28532775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns and trajectories in patients after acute heart failure hospitalization.
    Nakamaru R; Shiraishi Y; Kohno T; Nagatomo Y; Akiyama H; Motoya Y; Fukui M; Yajima T; Yoshikawa T; Kohsaka S
    ESC Heart Fail; 2024 Apr; 11(2):692-701. PubMed ID: 38098210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
    Casado J; Sánchez M; Garcés V; Manzano L; Cerqueiro JM; Epelde F; García-Escrivá D; Pérez-Silvestre J; Morales JL; Montero-Pérez-Barquero M;
    Int J Cardiol; 2017 Sep; 243():332-339. PubMed ID: 28528982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart Failure with Recovered Ejection Fraction in a Cohort of Elderly Patients with Chronic Heart Failure.
    Trullàs JC; Manzano L; Formiga F; Aramburu-Bodas O; Quesada-Simón MA; Arias-Jiménez JL; García-Escrivá D; Romero-Requena JM; Jordana-Comajuncosa R; Montero-Pérez-Barquero M;
    Cardiology; 2016; 135(3):196-201. PubMed ID: 27428545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.